Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: based on a Japanese Nationwide Survey
Ryogo Minamimoto(Graduate School USA), Tsuyoshi Yoshida(National Defense Academy of Japan), Michio Senda(Kyoto University), Sadahiko Nishizawa(Hamamatsu Photonics (Japan)), Kimiichi Uno(Nishida Hospital), Kazuhiro Oguchi(Aizawa Hospital), Eriko Tsukamoto, Shinya Oku(University of Aizu), Tomio Inoue(Yamagata University), Takeshi Iinuma, Takeshi Inoue(Shikoku Cancer Center), Kengo Ito(National Center for Geriatrics and Gerontology), Seishi Jinnouchi(Memorial), Takashi Terauchi(Families USA), Takeshi Murano(The University of Tokyo), Hiroshi Iwata(Brigham and Women's Hospital), Rumi Nakashima(Japanese Red Cross Kumamoto Hospital), Hiroshi Fukuda(Juntendo University)
Cited by 25
Related Papers
High performance plasma amyloid-β biomarkers for Alzheimer’s disease
|Nature|2018|1.7k
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
|NeuroImage|2002|839
A Randomized Controlled Trial of Multicomponent Exercise in Older Adults with Mild Cognitive Impairment
|PLoS ONE|2013|388
Somatosensory Homunculus as Drawn by MEG
|NeuroImage|1998|342
PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
|Nature Communications|2016|306